Cargando…
Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target
L-type amino acid transporter 1 (LAT1)/SLC7A5 is the first identified CD98 light chain disulfide linked to the CD98 heavy chain (CD98hc/SLC3A2). LAT1 transports large neutral amino acids, including leucine, which activates mTOR, and is highly expressed in human cancers. We investigated the oncogenic...
Autores principales: | Hayashi, Natsumi, Yamasaki, Akitaka, Ueda, Shiho, Okazaki, Shogo, Ohno, Yoshiya, Tanaka, Toshiyuki, Endo, Yuichi, Tomioka, Yoshihisa, Masuko, Kazue, Masuko, Takashi, Sugiura, Reiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238248/ https://www.ncbi.nlm.nih.gov/pubmed/34194623 http://dx.doi.org/10.18632/oncotarget.27981 |
Ejemplares similares
-
Dual‐targeting therapy against HER3/MET in human colorectal cancers
por: Yamasaki, Akitaka, et al.
Publicado: (2023) -
Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells
por: Hara, Yuta, et al.
Publicado: (2019) -
Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers
por: Okita, Kouki, et al.
Publicado: (2020) -
Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1
por: Hara, Yuta, et al.
Publicado: (2018) -
Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene
por: Okita, Kouki, et al.
Publicado: (2020)